Dr Pinakin Ramanbhai Amin, MD | |
11808 S Pulaski Rd, Alsip, IL 60803-1608 | |
(708) 489-6200 | |
Not Available |
Full Name | Dr Pinakin Ramanbhai Amin |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 38 Years |
Location | 11808 S Pulaski Rd, Alsip, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760593594 | NPI | - | NPPES |
036069991 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 036-069991 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Osf Little Company Of Mary Medical Center | Evergreen park, IL | Hospital |
Mailing Address | Practice Location Address |
---|---|
Dr Pinakin Ramanbhai Amin, MD 15531 Dewberry Ln, Orland Park, IL 60462-7719 Ph: () - | Dr Pinakin Ramanbhai Amin, MD 11808 S Pulaski Rd, Alsip, IL 60803-1608 Ph: (708) 489-6200 |
News Archive
Nationwide, more than one-quarter of hospital-based general practitioners who take over for patients' primary care doctors to manage inpatient care say their average patient load exceeds safe levels multiple times per month, according to a new Johns Hopkins study. Moreover, the study found that one in five of these physicians, known as hospitalists, reports that their workload puts patients at risk for serious complications, or even death.
For 25 years, researchers have tried and failed to develop an HIV vaccine, primarily by focusing on a small number of engineered "super antibodies" to fend off the virus before it takes hold.
BD, a leading global medical technology company announced today the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin R U-500 insulin, which is manufactured by Eli Lilly & Company.
More than 130 lawmakers are urging the Obama administration to expand coverage for a lung-cancer test under Medicare that could cost the program billons, calling the screening important for vulnerable seniors. In a letter to the Centers for Medicare and Medicaid Services, the lawmakers called for a timely decision on coverage for low-dose CT scans for older patients at higher risk of developing lung cancer. ... A CMS spokesman said the agency's decision will be based on whether the test is "reasonable and necessary," without regard to its cost to Medicare (Yen, 6/17).
› Verified 1 days ago